The intricate patterns of protein expression associated with the CNL/NSMP (copy-number low or nonspecific molecular profile) and CNH/p53 abnormal (copy-number high or p53 abnormal) categories play a crucial role in influencing the biological behavior and treatment responses in endometrial carcinoma. The gene discussed is TP53; the disease is endometrial carcinoma.